Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...

If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

A one-year-old baby boy has received an incredible honour, for helping researchers get one step closer to finding treatment ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

This list exemplifies the hard work in science over this past year, not simply in the lab but where it matters.

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Genetic modification improves environmental credentials of ‘particularly promising’ substitute that outperforms poultry, ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...